ENTASIS THERAPEUTICS HOLDINGS INC.: cashflow_financing
| Value | {"amount": 34301000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-06-30 |
| Status | current |
| Entity | ENTASIS THERAPEUTICS HOLDINGS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:38:22.061233+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c2c11308-72c2-42ce-80f7-059d9164f803
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-009666 · Open the official SEC filing →Retrieved: 2026-08-19T17:38:22.061233+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001724344/cashflow-financing/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c2c11308-72c2-42ce-80f7-059d9164f803
History
- no predecessors — first report